Authors:
BREITENSTEIN C
VANLANCKER D
KEMPLER D
DAUM I
WATERS CH
Citation: C. Breitenstein et al., THE CONTRIBUTION OF WORKING-MEMORY TO THE PERCEPTION OF EMOTIONAL PROSODY IN PARKINSONS-DISEASE, Brain and language (Print), 65(1), 1998, pp. 243-246
Authors:
KURTH MC
ADLER CH
STHILAIRE M
SINGER C
WATERS C
LEWITT P
CHERNIK DA
DORFLINGER EE
YOO K
LIEBERMAN AN
BREWER M
SAINTHILAIRE M
PERY LM
THOMAS C
TURPIN L
OBRIEN CF
SEEBERGER LC
DUNCAN KL
CAVINESS JN
DOUGLAS M
WHEELER K
RILEY D
RAINEY P
TANNER CM
KELKER K
LEWIS P
TROSCH RM
MISTURA KL
MONTGOMERY EB
LINDSEY B
WEINER W
SHULMAN LM
SHELDON C
WATERS CH
WELSH M
TRUGMAN JM
LANDOW ER
PEDDER SCJ
SHIMON GS
MAGNI G
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE EXPERIENCING MOTOR FLUCTUATIONS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Neurology, 48(1), 1997, pp. 81-87
Citation: Wt. Couldwell et al., VENTROPOSTERIOR MEDIAL PALLIDOTOMY IN PATIENTS WITH ADVANCED PARKINSONS-DISEASE - REPLY, Neurosurgery, 38(6), 1996, pp. 1261-1261
Authors:
HUTTON JT
KOLLER WC
AHLSKOG JE
PAHWA R
HURTIG HI
STERN MB
HINER BC
LIEBERMAN A
PFEIFFER RF
RODNITZKY RL
WATERS CH
MUENTER MD
ADLER CH
MORRIS JL
Citation: Jt. Hutton et al., MULTICENTER, PLACEBO-CONTROLLED TRIAL OF CABERGOLINE TAKEN ONCE-DAILYIN THE TREATMENT OF PARKINSONS-DISEASE, Neurology, 46(4), 1996, pp. 1062-1065
Authors:
WATERS CH
KURTH MC
SHULMAN L
BAILEY P
SHALE H
DORFLINGER E
YOO K
SHIMOUN G
PEDDER S
Citation: Ch. Waters et al., EVALUATION OF THE EFFICACY AND SAFETY OF TOLCAPONE (TASMAR) IN PARKINSONS-DISEASE PATIENTS WITH A STABLE RESPONSE TO LEVODOPA, Neurology, 46(2), 1996, pp. 4006-4006
Citation: Md. Welsh et al., PSYCHOSOCIAL ADJUSTMENT AND ILLNESS IMPACT IN PARKINSONS-DISEASE PATIENTS BEFORE AND AFTER TREATMENT WITH TOLCAPONE (TASMAR), Neurology, 46(2), 1996, pp. 4129-4129
Authors:
CARMEL R
GOTT PS
WATERS CH
CAIRO K
GREEN R
BONDAREFF W
DEGIORGIO CM
CUMMINGS JL
JACOBSEN DW
BUCKWALTER G
HENDERSON VW
Citation: R. Carmel et al., THE FREQUENTLY LOW COBALAMIN LEVELS IN DEMENTIA USUALLY SIGNIFY TREATABLE METABOLIC, NEUROLOGIC AND ELECTROPHYSIOLOGIC ABNORMALITIES, European journal of haematology, 54(4), 1995, pp. 245-253
Authors:
LEW MF
SHINDO M
MOSKOWITZ CB
WILHELMSEN KC
FAHN S
WATERS CH
Citation: Mf. Lew et al., ADDUCTOR LARYNGEAL BREATHING DYSTONIA IN A PATIENT WITH LUBAG (X-LINKED DYSTONIA-PARKINSONISM SYNDROME), Movement disorders, 9(3), 1994, pp. 318-320
Citation: Mf. Lew et Ch. Waters, CLOZAPINE TREATMENT OF PARKINSONISM WITH PSYCHOSIS, Journal of the American Geriatrics Society, 41(6), 1993, pp. 669-671